EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Incidence of Type 1 Diabetes in Sweden During 2008–2021

Yazan Al Abed iD, Araz Rawshani, Aidin Rawshani, Björn Eliasson iD, Mohammad Al Masri, Gustaf Lernfelt, Daniel Novak, Joanna Pestalozzi, Maria Henningsson

Acta Paediatrica · 2025

DOI: 10.1111/apa.70226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Paediatrica, 2025. Verfasst von Yazan Al Abed und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

We analysed type 1 diabetes incidence in individuals aged 0–24 years from 2008 to 2021, with a focus on age at onset and potential changes during the COVID‐19 pandemic.

Methods

Type 1 diabetes incidence was assessed using insulin prescriptions from the Prescribed Drug Register. One or more prescriptions defined a case in males; three or more were required in females. Data were stratified into 5‐year age groups and analysed over the 2008–2021 period.

Results

Type 1 diabetes incidence increased by 12% in individuals aged 0–24 years in 2021 compared to 2008–2019. The highest 2021 incidence was observed in the 0–4, 5–9 and 20–24 age groups. The 10–14 group consistently had the highest rates overall, followed by 5–9, 15–19, 20–24 and 0–4. Incidence was stable prepandemic, and a significant decline in age at onset was observed over time.

Conclusions

A shift in the age of onset of type 1 diabetes towards younger ages was observed between 2008 and 2021. The increased incidence in 2021 could be influenced by a possible delayed effect of the widespread SARS‐CoV‐2 infections during the COVID‐19 pandemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1COVID-19HumansIncidenceAdolescentChildMaleFemaleSwedenChild, PreschoolInfantYoung AdultInfant, NewbornAge of OnsetRegistries

Autor:innen und Institutionen

  • Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Wallenberg Centre for Molecular and Clinical Research (WCMTM), University of Gothenburg, Gothenburg, Sweden.
  • Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Centre for Registers in Region Västra Götaland, Gothenburg, Sweden.
  • Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Pediatrics, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.

ORCID-Profile: Yazan Al Abed, Björn Eliasson

Zitieren

APA

Al Abed, Y., Rawshani, A., Rawshani, A., Eliasson, B., Al Masri, M., Lernfelt, G., Novak, D., Pestalozzi, J., & Henningsson, M. (2025). The Incidence of Type 1 Diabetes in Sweden During 2008–2021. Acta Paediatrica. https://doi.org/10.1111/apa.70226

Vancouver

Al Abed Y, Rawshani A, Rawshani A, Eliasson B, Al Masri M, Lernfelt G, et al. The Incidence of Type 1 Diabetes in Sweden During 2008–2021. Acta Paediatrica. 2025. doi:10.1111/apa.70226

BibTeX
@article{AlAbed2025,
  author = {Al Abed, Yazan and Rawshani, Araz and Rawshani, Aidin and Eliasson, Björn and Al Masri, Mohammad and Lernfelt, Gustaf and Novak, Daniel and Pestalozzi, Joanna and Henningsson, Maria},
  title = {The Incidence of Type 1 Diabetes in Sweden During 2008–2021},
  journal = {Acta Paediatrica},
  year = {2025},
  doi = {10.1111/apa.70226}
}
Kostenlos starten →